Navigation Links
Essilor : First Half 2009 Revenue
Date:7/16/2009 

    - Strong Growth in First-Half Revenue, up 9.4%

    - Operating Margin Holds Firm

Essilor International, the world leader in ophthalmic optics, today announced consolidated revenue of an estimated EUR1,663.4 million for the six months ended June 30, 2009, representing a reported 9.4% increase on first-half 2008. Like-for-like, revenue was down a slight 0.7% for the period, but was up 5.3% excluding the currency effect alone.

In a generally sluggish ophthalmic optics market, Essilor primarily relied on new product launches to sustain its lens sales. Market share increased worldwide, led by the Company's extensive product portfolio, strong distribution networks and targeted acquisitions dynamic.

In light of these factors, Essilor is confident in its ability to maintain first-half 2009 operating margin on a par with full-year 2008.

    Consolidated revenue for the first six months of 2009

    EUR millions  H1 2009  H1 2008  % Change    % Change        Contribution
                                    (reported*) (like-for-like) from
                                                                acquisitions
    Total         1,663.4  1,520.2    +9.4%       -0.7%           +6.0%
    Europe          665.1    693.5    -4.1%       -4.4%           +2.0%
    North America   718.1    617.9   +16.2%       -0.9%           +4.3%
    Asia-Pacific    170.1    146.8   +15.9%       +13.5%          +1.3%
    Latin America    60.3     60.6    -0.5%        +9.4%          +0.7%
    Laboratory       49.8**    1.4***  N/M          N/M            N/M
    equipment (1)


    (*) Of which 4.1% due to the currency effect
    (**) Excluding EUR14.8 million in Satisloh revenue from sales to Essilor
    (***) Satisloh was not part of the Group in first-half 2008.

Improving performance in the second quarter: the like-for-like decrease in first-half revenue included a decline of 1.0
'/>"/>

SOURCE Essilor
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Essilor: Essilor Forges New Strategic Partnerships Around the World
2. Essilor : 2009 First Quarter Report
3. Essilor Cancels 1,600,000 Shares
4. Essilor Finalizes Satisloh Agreement
5. Essilors First-Half 2008 Results
6. Essilor : Nomination of Hubert Sagnieres
7. Essilor: New Acquisitions in the United States and Brazil
8. Essilor Cancels 700,000 Shares
9. Essilors 2007 Third-Quarter Report
10. Sumavel(TM) DosePro(TM) (sumatriptan injection) Approved by FDA for Acute Migraine and Cluster Headache: First Product Featuring Novel DosePro Needle-Free Delivery System
11. China Biologic Products Hosts its First Forum for Strategy and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... NANONEX CORPORATION, a pioneer and leading company ... successful delivery and installation of a new nanoimprint ... major Japanese manufacturing company. , ... lithography tool that has the ability to process ... types. Based on Nanonex inventions and proprietary technologies, ...
(Date:5/21/2013)... 21, 2013 SoundConnect is pleased to ... Lync, for customers in Canada. Lync is the ... will allow businesses and organizations to collaborate and communicate ... released Lync in the United States. With the progressive ... product release in Canada, SoundConnect now offers a complete ...
(Date:5/20/2013)... 2013 , Collaboration with ... (ARS) in treatment of mastitis , ... Trials to begin in the second half 2013 ... Phosphagenics Limited (ASX: POH, OTCQX: PPGNY) will ... Research Service (ARS) to develop and trial products targeting ...
(Date:5/20/2013)... , May 20, 2013 Today, at ... San Francisco , James McGough ... Psychiatry at the Semel Institute for Neuroscience and Human ... of Medicine at the University of California Los Angeles ... Child and Adolescent Psychopharmacology and ADHD at UCLA, presented ...
Breaking Biology Technology:Nanonex Announces the Shipment and Installation of an Innovative Nanoimprint Lithography System for Fully Automated Manufacturing 2SoundConnect Announces Microsoft Lync Release in Canada 2SoundConnect Announces Microsoft Lync Release in Canada 3Phosphagenics Signs Research Agreement with the Agricultural Research Service 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5
... Audio Webcast Tuesday, September 11, 2007, SAN DIEGO, ... announced today that Neurocrine Biosciences will,present at the Bear ... 11, 2007 at 10:30 a.m. Eastern Time (ET),/7:30 a.m. ... may be accessed on the Company,s website at, http://www.neurocrine.com ...
... that NKTR-118 Shows Promise for the Treatment of Opioid ... ... Calif., Sept. 10 Nektar,Therapeutics (Nasdaq: NKTR ) presented ... San Francisco, California from a,Phase 1 trial of NKTR-118 (oral ...
... BioStorage Technologies, Inc.,(BST) announced that it has ... (IPL) to purchase electricity generated by 100 percent,renewable ... By offsetting the use of fossil-fueled power generation, ... carbon-neutral by 2009. BST becomes the third-largest ...
Cached Biology Technology:Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting 2Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting 3Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting 4Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting 5BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy 2BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy 3BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy 4
(Date:5/21/2013)... shows that the nation,s land and water resources could ... up to 25 billion gallons of algae-based fuel a ... yearly needs. , The findings come from an in-depth ... to grow significant amounts of algae in large, specially ... May 7 issue of Environmental Science and Technology ...
(Date:5/21/2013)... Mo. Cancers of all types become most deadly ... Once cancer has reached this stage, it becomes very ... tumors that can develop. Now, researchers at the University ... nanoparticles that target lymphoma tumor cells wherever they may ... of oncology in the MU College of Veterinary Medicine, ...
(Date:5/21/2013)... in shape is an uphill battle? Try staying fit ... weightlessness withers muscle and bone. , That,s the challenge ... with a new three-year, $1.2 million grant from NASA. ... during multiyear exploratory missions. , "You could give astronauts ... can,t get them to stick to it, it isn,t ...
Breaking Biology News(10 mins):Going green: Nation equipped to grow serious amounts of pond scum for fuel 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 4MU researchers develop radioactive nanoparticles that target cancer cells 2Fueling fitness on the final frontier 2
... means Kansas State University ecologists will get more help ... opportunities for eight to 10 undergraduate students each summer ... Jumpponen, associate professors of biology, and Bruce Snyder, instructor ... National Science Foundation to help K-State continue to be ...
... Aug. 26 An exploration of the molecular links between ... for diabetes treatment, say scientists at the John G. Rangos ... findings were published earlier this month in the online version ... American Diabetes Association. Signs of low-grade systemic inflammation ...
... are increasingly offering genetic tests directly to consumers to assess ... These tests have raised concerns over whether people will receive ... by health care providers -- and whether consumers, genetic information ... On Aug. 31 and Sept. 1 the National Research ...
Cached Biology News:Pitt study finds molecular link between insulin resistance and inflammation 2
2-min, single-step add-mix-measure assay for luciferase expression and HTS in mammalian cells. Linear detection range: 2 fg to 46 ng luciferase....
Endomorphin-2. Cross reactivity: Endomorphin-1 3%, Met-enkephalin <0.03%, Leu-enkephalin <0.01% and beta-Endorphin <0.01%....
... cloning of BAC (100+kb), fosmid (40kb), and ... stability than any othe BAC vector. On ... yields and easy recombinant DNA purification. Available ... (pSMART VC) vectors for the highest insert ...
... System is used in conjunction ... PCR of problematic and/or GC-rich ... Solution with 10X PCRX Amplification ... broader magnesium concentration broader annealing ...
Biology Products: